Health policy and economic analysis

First and foremost is the question of how to determine when the overall quality of evidence is adequate to demonstrate medical necessity for individual technologies and services.

Annu Rev Med — Iversen T, Luras H. We believe that lack of guidance on what is the most efficient way to reduce medical errors and improve the quality of health-care limits the scale-up of health system improvement interventions. Students will be asked to record a video on their own on a topic that will be assigned to them.

Many public and private payers have taken a very different approach over the last several years, investing considerable resources to make the medical policy process more scientific and transparent.

Only at the level of these individual decisions, it is argued, can all the subtle variations in clinical presentation and social context be thoroughly understood and factored into determinations about what is the best medically necessary care for the patient.

Herbst, C. Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal.

economic evaluation in health care pdf

Interventions, such as antihypertensive and antiplatelet medications, are generally established as sufficiently cost-effective to reduce the risk of IHD and stroke.

One possible solution is to measure the process indicators as is feasible but then use epidemiological modeling to relate those process measures to tangible health outcomes using the best available evidence of the link between the process and ultimate outcomes.

For illustration, we discuss a cost-effectiveness analysis of the use of uterotonics during the third stage of labor to reduce the risk of post-partum hemorrhage PPH in Senegal as an example of a simple, well-defined individual medical intervention that has a single basic intended effect 18 in contrast to the cost-effectiveness analysis of a HSII to improve compliance with essential obstetric and newborn care including the use of uterotonics in the third stage of labor in Niger

Economic evaluation in health care slideshare

It is clear that there are multiple competing demands on health-care resources in all settings, and by definition this is especially the case in low- and middle-income settings. In this model, clinicians attempt to identify the clinical intervention that best meets the patient's need, separating this clinical decision from any consideration of what the indirect impact of this decision might be. The course will present key theoretical concepts and use empirical evidence particularly relevant for policy questions in low- and middle-income settings. Currie, J. J Am Med Inform Assoc 22 4 — Clinical studies are evaluated through the well-described framework of evidence-based medicine, and decision memos are now posted on the coverage Web site, providing detailed explanations of what evidence was reviewed and how the coverage policy was derived from the evidence. It could be viewed as ethically dubious in such settings to implement an HSII without examination of its economic consequences because, without knowing if the intervention is affordable, sustainable, or acceptably efficient, information on its effectiveness alone is not useful. World Health Organization. Washington, DC: World Bank.
Rated 9/10 based on 63 review
HP Economic Analysis for Health Policy in Low